End-of-day quote
Korea S.E.
03:30:00 03/05/2024 am IST
|
5-day change
|
1st Jan Change
|
5,640
KRW
|
-1.05%
|
|
+0.89%
|
-9.62%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,37,308
|
3,24,839
|
3,06,192
|
Enterprise Value (EV)
1 |
5,05,901
|
2,89,207
|
3,20,139
|
P/E ratio
|
120
x
|
583
x
|
63.7
x
|
Yield
|
-
|
-
|
0.16%
|
Capitalization / Revenue
|
6.3
x
|
3.13
x
|
2.51
x
|
EV / Revenue
|
5.93
x
|
2.79
x
|
2.62
x
|
EV / EBITDA
|
70.1
x
|
58.6
x
|
33.2
x
|
EV / FCF
|
-
|
-2,88,43,306
x
|
-78,49,148
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
Price to Book
|
6.46
x
|
3.55
x
|
3.18
x
|
Nbr of stocks (in thousands)
|
49,069
|
49,069
|
49,069
|
Reference price
2 |
10,950
|
6,620
|
6,240
|
Announcement Date
|
21/03/23
|
21/03/23
|
20/03/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net sales
1 |
85,354
|
1,03,711
|
1,21,998
|
EBITDA
1 |
7,215
|
4,932
|
9,643
|
EBIT
1 |
6,109
|
3,488
|
6,509
|
Operating Margin
|
7.16%
|
3.36%
|
5.34%
|
Earnings before Tax (EBT)
1 |
5,084
|
11,088
|
1,738
|
Net income
1 |
4,038
|
8,948
|
4,824
|
Net margin
|
4.73%
|
8.63%
|
3.95%
|
EPS
2 |
91.00
|
11.35
|
98.00
|
Free Cash Flow
|
-
|
-10,027
|
-40,786
|
FCF margin
|
-
|
-9.67%
|
-33.43%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
10.00
|
Announcement Date
|
21/03/23
|
21/03/23
|
20/03/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
13,947
|
Net Cash position
1 |
31,407
|
35,632
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.446
x
|
Free Cash Flow
|
-
|
-10,027
|
-40,786
|
ROE (net income / shareholders' equity)
|
-
|
10.1%
|
4.94%
|
ROA (Net income/ Total Assets)
|
-
|
1.44%
|
1.93%
|
Assets
1 |
-
|
6,22,026
|
2,49,733
|
Book Value Per Share
2 |
1,695
|
1,867
|
1,965
|
Cash Flow per Share
2 |
389.0
|
439.0
|
224.0
|
Capex
1 |
10,409
|
23,285
|
43,923
|
Capex / Sales
|
12.19%
|
22.45%
|
36%
|
Announcement Date
|
21/03/23
|
21/03/23
|
20/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -9.62% | 204M | | +20.45% | 43.95B | | +22.22% | 22.49B | | +14.60% | 14.71B | | +11.00% | 13.77B | | +42.59% | 12.3B | | -8.70% | 7.03B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +11.75% | 5.48B |
Generic Pharmaceuticals
|